{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:57:19Z","timestamp":1790848639013,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:00:00Z","timestamp":1707004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ad.2023.10.043","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T03:53:32Z","timestamp":1707278012000},"page":"T347-T355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["[Translated article] Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Hair Disorders Group of the Spanish Academy of Dermatology and Venererology (AEDV)"],"prefix":"10.1016","volume":"115","author":[{"given":"S.","family":"Va\u00f1\u00f3-Galv\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fernandez-Crehuet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Garnacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"G\u00f3mez-Zubiaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hermosa-Gelbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.M.","family":"Moreno-Arrones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Saceda-Corralo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Serrano-Falc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2023.10.043_bib0230","first-page":"32","article-title":"Androgenetic Alopecia Treatment in Asian Men","volume":"11","author":"Tanaka","year":"2018","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0738-081X(00)00128-0","article-title":"Androgenetic alopecia in men and women","volume":"19","author":"Sinclair","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0240","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jvc2.53","article-title":"The state-of-the-art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms","volume":"3","author":"Dominguez-Santas","year":"2022","journal-title":"JEADV Clinical Practice"},{"key":"10.1016\/j.ad.2023.10.043_bib0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jdv.14624","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men \u2013 short version","volume":"32","author":"Kanti","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.10.043_bib0250","first-page":"E64","article-title":"A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use Low-Level Light\/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology","volume":"14","author":"Lueangarun","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0255","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4103\/JCAS.JCAS_218_20","article-title":"Role of Low-Level Light Therapy (LLLT) in Androgenetic Alopecia","volume":"14","author":"Pillai","year":"2021","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1016\/j.ad.2023.10.043_bib0260","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/DSS.0000000000001577","article-title":"Efficacy and safety of a low-level light therapy for androgenetic alopecia: A 24-week, randomized, double-blind, self-comparison, sham device-controlled trial","volume":"44","author":"Fan","year":"2018","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2023.10.043_bib0265","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijwd.2018.08.004","article-title":"Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol","volume":"5","author":"Stevens","year":"2019","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0270","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jaad.2020.07.006","article-title":"Evaluation of platelet-rich plasma as a\u00a0treatment for androgenetic alopecia: A randomized controlled trial","volume":"83","author":"Shapiro","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0275","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/01.DSS.0000452629.76339.2b","article-title":"Platelet-rich plasma for androgenetic alopecia: A pilot study","volume":"40","author":"Schiavone","year":"2014","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2023.10.043_bib0280","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1016\/j.jaad.2020.12.038","article-title":"Side effects of low-dose oral minoxidil for treating alopecia","volume":"84","author":"Beach","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0285","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11154-015-9319-y","article-title":"Adverse effects of 5\u03b1-reductase inhibitors: What do we know, don\u2019t know, and need to know?","volume":"16","author":"Traish","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.ad.2023.10.043_bib0290","article-title":"Long-Term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction","volume":"30","author":"Traish","year":"2017","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.ad.2023.10.043_bib0295","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.ad.2023.10.043_bib0300","unstructured":"Centre for Evidence-Based Medicine (CEBM), University of Oxford. Oxford Centre for Evidence-Based Medicine: Levels of Evidence [accessed July 29, 2023] Available from: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009"},{"key":"10.1016\/j.ad.2023.10.043_bib0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2010.10011.x","article-title":"S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents","volume":"164","author":"Blume-Peytavi","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0310","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s40265-016-0629-5","article-title":"Androgenetic Alopecia: An Update of Treatment Options","volume":"76","author":"Kelly","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ad.2023.10.043_bib0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dth.13059","article-title":"Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti-androgens","volume":"32","author":"Katzer","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.10.043_bib0320","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2006.05.007","article-title":"The importance of dual 5(-reductase inhibition in\u00a0the\u00a0treatment of male pattern hair loss: Results\u00a0of\u00a0a\u00a0randomized placebo-controlled study\u00a0of\u00a0dutasteride versus finasteride","volume":"55","author":"Olsen","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2013.10.049","article-title":"A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia","volume":"70","author":"Gubelin Harcha","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0330","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/09546634.2013.813011","article-title":"The efficacy and safety of 5\u03b1-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit\u2013risk assessment of finasteride and dutasteride","volume":"25","author":"Gupta","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2023.10.043_bib0335","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2019.08.060","article-title":"Minoxidil 1mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial","volume":"82","author":"Ramos","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0340","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jaad.2019.04.054","article-title":"Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia","volume":"81","author":"Jimenez-Cauhe","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0345","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/jdv.17216","article-title":"Review of oral minoxidil as treatment of hair disorders: In search of the perfect dose","volume":"35","author":"Villani","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.10.043_bib0350","doi-asserted-by":"crossref","first-page":"e14106","DOI":"10.1111\/dth.14106","article-title":"Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data","volume":"33","author":"Jimenez-Cauhe","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.10.043_bib0355","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaad.2021.02.054","article-title":"Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients","volume":"84","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0360","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12686","article-title":"Minoxidil in the treatment of androgenetic alopecia","volume":"31","author":"Goren","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.10.043_bib0365","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ijd.13838","article-title":"Female pattern hair loss: A pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone","volume":"57","author":"Sinclair","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0370","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/j.jaad.2020.04.054","article-title":"Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss","volume":"83","author":"Fernandez-Nieto","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0375","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jaad.2020.03.034","article-title":"Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients","volume":"83","author":"Ismail","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0380","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1111\/jocd.14773","article-title":"Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know","volume":"21","author":"de Melo Carvalho","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0385","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: A controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0390","unstructured":"European Medicines Agency. Restrictions in use of cyproterone due to meningioma risk [accessed Sep 19 2022] Available from: https:\/\/www.ema.europa.eu\/en\/news\/restrictions-use-cyproterone-due-meningioma-risk"},{"key":"10.1016\/j.ad.2023.10.043_bib0395","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/039463201202500435","article-title":"Comparitive Effectiveness and Finasteride Vs Serenoa Repens in Male Androgenetic Alopecia: A Two-Year Study","volume":"25","author":"Rossi","year":"2012","journal-title":"Int J Immunopathol Pharmacol."},{"key":"10.1016\/j.ad.2023.10.043_bib0400","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ad.2020.03.001","article-title":"Uso de la espironolactona en dermatolog\u00eda: acn\u00e9, hidradenitis supurativa, alopecia femenina e hirsutismo","volume":"111","author":"Vargas-Mora","year":"2020","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2023.10.043_bib0405","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1468-3083.2012.04535.x","article-title":"Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: Photographic, morphometric and ultrustructural evaluation","volume":"27","author":"Moftah","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.10.043_bib0410","first-page":"1","article-title":"Comparing the efficacy of mesotherapy to topical minoxidil in the treatment of female pattern hair loss using ultrasound biomicroscopy: A randomized controlled trial","volume":"27","author":"Hunter","year":"2019","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.ad.2023.10.043_bib0415","doi-asserted-by":"crossref","first-page":"943","DOI":"10.36849\/JDD.6948","article-title":"Platelet-Rich Plasma Monotherapies for Androgenetic Alopecia: A Network Meta-Analysis and Meta-Regression Study","volume":"21","author":"Gupta","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2023.10.043_bib0420","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/DSS.0000000000001584","article-title":"Injectable platelet-, leukocyte-, and fibrin-rich plasma (iL-PRF) in the management of androgenetic alopecia","volume":"44","author":"Schiavone","year":"2018","journal-title":"Dermatologic Surgery"},{"key":"10.1016\/j.ad.2023.10.043_bib0425","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5966\/sctm.2015-0107","article-title":"The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial","volume":"4","author":"Gentile","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.ad.2023.10.043_bib0430","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00044011-200929050-00001","article-title":"HairMax LaserComb\u00ae laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial","volume":"29","author":"Leavitt","year":"2009","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ad.2023.10.043_bib0435","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.det.2012.08.012","article-title":"Hair Transplantation Update. Procedural Techniques Innovations, and Applications","volume":"31","author":"Kristine Bunagan","year":"2013","journal-title":"Dermatol Clin"},{"issue":"Suppl 2","key":"10.1016\/j.ad.2023.10.043_bib0440","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jdv.17601","article-title":"Current controversies in trichology: A European expert consensus statement","volume":"35","author":"Meyer-Gonzalez","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.10.043_bib0445","doi-asserted-by":"crossref","first-page":"185","DOI":"10.9734\/jpri\/2021\/v33i49B33355","article-title":"Hair Transplant: Challenges Solutions and Guideline for Beginners","volume":"33","author":"Gawande","year":"2021","journal-title":"J Pharm Res Int"},{"key":"10.1016\/j.ad.2023.10.043_bib0450","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jaad.2019.08.018","article-title":"Pediatric androgenetic alopecia: A review","volume":"85","author":"Griggs","year":"2021","journal-title":"J Am Acad Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:43:10Z","timestamp":1720539790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731024000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0001731024000887"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2023.10.043","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Hair Disorders Group of the Spanish Academy of Dermatology and Venererology (AEDV)","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.10.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.10.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of AEDV.","name":"copyright","label":"Copyright"}]}}